{"id":"https://openalex.org/W3016524908","doi":"https://doi.org/10.1016/j.omtm.2020.04.009","title":"Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus","display_name":"Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus","publication_year":2020,"publication_date":"2020-04-15","ids":{"openalex":"https://openalex.org/W3016524908","doi":"https://doi.org/10.1016/j.omtm.2020.04.009","mag":"3016524908","pmid":"https://pubmed.ncbi.nlm.nih.gov/32296729"},"language":"en","primary_location":{"id":"doi:10.1016/j.omtm.2020.04.009","doi":"https://doi.org/10.1016/j.omtm.2020.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2020.04.009","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Methods &amp; Clinical Development","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.omtm.2020.04.009","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070162381","display_name":"John J. Suschak","orcid":"https://orcid.org/0000-0002-2867-8265","observed_orcids":["https://orcid.org/0000-0002-2867-8265"]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John J. Suschak","raw_affiliation_strings":["Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA","institution_ids":["https://openalex.org/I2801122164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066047183","display_name":"Lesley C. Dupuy","orcid":"https://orcid.org/0000-0002-3796-6760","observed_orcids":["https://orcid.org/0000-0002-3796-6760"]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lesley C. Dupuy","raw_affiliation_strings":["Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA","institution_ids":["https://openalex.org/I2801122164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008960638","display_name":"Charles J. Shoemaker","orcid":"https://orcid.org/0000-0002-8974-7033","observed_orcids":["https://orcid.org/0000-0002-8974-7033"]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles J. Shoemaker","raw_affiliation_strings":["Diagnostic Systems Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diagnostic Systems Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA","institution_ids":["https://openalex.org/I2801122164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023659051","display_name":"Carolyn M. Six","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn Six","raw_affiliation_strings":["Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA","institution_ids":["https://openalex.org/I2801122164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047874446","display_name":"Steven A. Kwilas","orcid":"https://orcid.org/0000-0003-0383-3879","observed_orcids":["https://orcid.org/0000-0003-0383-3879"]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven A. Kwilas","raw_affiliation_strings":["Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA","institution_ids":["https://openalex.org/I2801122164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072202643","display_name":"Kristin W. Spik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin W. Spik","raw_affiliation_strings":["Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA","institution_ids":["https://openalex.org/I2801122164"]}]},{"author_position":"middle","author":{"id":null,"display_name":"James A. Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090215","display_name":"Nature Technology Corporation (United States)","ror":"https://ror.org/00a75q479","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James A. Williams","raw_affiliation_strings":["Nature Technology Corporation, Lincoln, NE 68521, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nature Technology Corporation, Lincoln, NE 68521, USA","institution_ids":["https://openalex.org/I4210090215"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022884834","display_name":"Connie S. Schmaljohn","orcid":"https://orcid.org/0000-0001-8852-5482","observed_orcids":["https://orcid.org/0000-0001-8852-5482","https://orcid.org/0000-0002-8834-0784"]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Connie S. Schmaljohn","raw_affiliation_strings":["Headquarters, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Headquarters, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA","institution_ids":["https://openalex.org/I2801122164"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5066047183","https://openalex.org/A5070162381"],"corresponding_institution_ids":["https://openalex.org/I2801122164"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":1.5172,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.82999965,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"17","issue":null,"first_page":"810","last_page":"821"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4399000108242035,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4399000108242035,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10166","display_name":"Mosquito-borne diseases and control","score":0.1453000009059906,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11767","display_name":"Poxvirus research and outbreaks","score":0.10939999669790268,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-vaccine","display_name":"DNA vaccine","score":0.9229999780654907},{"id":"https://openalex.org/keywords/venezuelan-equine-encephalitis-virus","display_name":"Venezuelan equine encephalitis virus","score":0.9879999756813049},{"id":"https://openalex.org/keywords/ebola-virus","display_name":"Ebola virus","score":1.0},{"id":"https://openalex.org/keywords/glycoprotein-gene","display_name":"glycoprotein gene","score":0.7310000061988831},{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.8149999976158142},{"id":"https://openalex.org/keywords/electroporation","display_name":"electroporation","score":0.7639999985694885},{"id":"https://openalex.org/keywords/aerosol-challenge","display_name":"aerosol challenge","score":0.7049999833106995},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.699999988079071},{"id":"https://openalex.org/keywords/alphavirus","display_name":"alphavirus","score":0.6579999923706055},{"id":"https://openalex.org/keywords/filoviruses","display_name":"filoviruses","score":1.0}],"concepts":[{"id":"https://openalex.org/C2777062976","wikidata":"https://www.wikidata.org/wiki/Q473462","display_name":"Venezuelan equine encephalitis virus","level":4,"score":0.8471684455871582},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.8430719375610352},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.8205561637878418},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.6284024715423584},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6252861618995667},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6138787269592285},{"id":"https://openalex.org/C2777469322","wikidata":"https://www.wikidata.org/wiki/Q8064876","display_name":"Ebola virus","level":3,"score":0.6057908535003662},{"id":"https://openalex.org/C2777474056","wikidata":"https://www.wikidata.org/wiki/Q1111605","display_name":"Alphavirus","level":3,"score":0.5360700488090515},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5104905366897583},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4615824818611145},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4424581825733185},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4352869987487793},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.42579641938209534},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.42304131388664246},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2660123109817505},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.2024572193622589}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.1016/j.omtm.2020.04.009","doi":"https://doi.org/10.1016/j.omtm.2020.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2020.04.009","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Methods &amp; Clinical Development","raw_type":"journal-article"},{"id":"pmid:32296729","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32296729","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy. Methods & clinical development","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7158766","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7158766","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Mol Ther Methods Clin Dev","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:5e92262ec1494a2dad07a322eb11bedc","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5e92262ec1494a2dad07a322eb11bedc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 810-821 (2020)","raw_type":"article"},{"id":"pmh:oai:osti.gov:1616216","doi":null,"is_oa":false,"landing_page_url":"https://www.osti.gov/biblio/1616216","pdf_url":null,"source":{"id":"https://openalex.org/S4306402487","display_name":"OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139351228","host_organization_name":"Office of Scientific and Technical Information","host_organization_lineage":["https://openalex.org/I139351228"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},{"id":"pmh:oai:osti.gov:1816514","doi":null,"is_oa":false,"landing_page_url":"https://www.osti.gov/biblio/1816514","pdf_url":null,"source":{"id":"https://openalex.org/S4306402487","display_name":"OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139351228","host_organization_name":"Office of Scientific and Technical Information","host_organization_lineage":["https://openalex.org/I139351228"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1016/j.omtm.2020.04.009","doi":"https://doi.org/10.1016/j.omtm.2020.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2020.04.009","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Methods &amp; Clinical Development","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6399999856948853}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320332186","display_name":"Defense Threat Reduction Agency","ror":"https://ror.org/04tz64554"},{"id":"https://openalex.org/F4320332382","display_name":"Oak Ridge Institute for Science and Education","ror":"https://ror.org/0526p1y61"},{"id":"https://openalex.org/F4320332447","display_name":"U.S. Army","ror":"https://ror.org/00afsp483"},{"id":"https://openalex.org/F4320338280","display_name":"Medical Research and Materiel Command","ror":"https://ror.org/03cd02q50"},{"id":"https://openalex.org/F4320338323","display_name":"U.S. Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W235839431","https://openalex.org/W1540299868","https://openalex.org/W1667435701","https://openalex.org/W1746466700","https://openalex.org/W1759518163","https://openalex.org/W1964672881","https://openalex.org/W1970758220","https://openalex.org/W1972591948","https://openalex.org/W1977752725","https://openalex.org/W1979250710","https://openalex.org/W1981642403","https://openalex.org/W1982830459","https://openalex.org/W1989676021","https://openalex.org/W1998969688","https://openalex.org/W2006143353","https://openalex.org/W2010907373","https://openalex.org/W2011356365","https://openalex.org/W2014893474","https://openalex.org/W2028463307","https://openalex.org/W2053761308","https://openalex.org/W2053801470","https://openalex.org/W2055766303","https://openalex.org/W2064871758","https://openalex.org/W2065818546","https://openalex.org/W2067174670","https://openalex.org/W2068958563","https://openalex.org/W2072630610","https://openalex.org/W2089712328","https://openalex.org/W2091303798","https://openalex.org/W2094175565","https://openalex.org/W2095028793","https://openalex.org/W2096745064","https://openalex.org/W2097884047","https://openalex.org/W2100081088","https://openalex.org/W2108218913","https://openalex.org/W2119171379","https://openalex.org/W2123076394","https://openalex.org/W2128406623","https://openalex.org/W2134066463","https://openalex.org/W2144150351","https://openalex.org/W2145340095","https://openalex.org/W2175593937","https://openalex.org/W2320122886","https://openalex.org/W2396210930","https://openalex.org/W2409922262","https://openalex.org/W2504280389","https://openalex.org/W2610893655","https://openalex.org/W2622096159","https://openalex.org/W2883067302","https://openalex.org/W2892925894","https://openalex.org/W6753164909"],"related_works":["https://openalex.org/W4321438708","https://openalex.org/W1970605491","https://openalex.org/W3192065043","https://openalex.org/W2559572162","https://openalex.org/W2770157223","https://openalex.org/W2195567157","https://openalex.org/W10640494","https://openalex.org/W2143845740","https://openalex.org/W3206954814","https://openalex.org/W2026662338"],"abstract_inverted_index":{"DNA":[0,45,61,123,139,150,165,197],"vaccines":[1,46,99,124,151],"expressing":[2],"codon-optimized":[3],"Venezuelan":[4],"equine":[5],"encephalitis":[6],"virus":[7,11],"(VEEV)":[8],"and":[9,20,43,105,147,190,195],"Ebola":[10],"(EBOV)":[12],"glycoprotein":[13],"genes":[14,78,173],"provide":[15],"protective":[16,33,191],"immunity":[17],"to":[18,69,93,135,175],"mice":[19,86,143,160],"nonhuman":[21],"primates":[22],"when":[23,100],"delivered":[24,101],"by":[25,102,111],"intramuscular":[26],"(IM)":[27],"electroporation":[28],"(EP).":[29],"To":[30],"achieve":[31],"equivalent":[32],"efficacy":[34,192],"in":[35],"the":[36,112,115,136,145,153,162,169,188],"absence":[37],"of":[38,114,193],"EP,":[39],"we":[40],"evaluated":[41],"VEEV":[42,122,131,138],"EBOV":[44,149,157,164],"constructed":[47],"using":[48],"minimalized":[49],"Nanoplasmid":[50,84,121,148,163,184],"expression":[51],"vectors":[52,64,185],"that":[53,79,167,183],"are":[54],"smaller":[55],"than":[56],"conventional":[57,97],"plasmids":[58],"used":[59],"for":[60],"vaccination.":[62],"These":[63],"may":[65],"also":[66,125],"be":[67],"designed":[68],"co-express":[70],"type":[71],"I":[72],"interferon":[73],"inducing":[74],"innate":[75,116,170],"immune":[76,117,171],"agonist":[77,118,172],"have":[80],"an":[81],"adjuvant":[82],"effect.":[83],"vaccinated":[85],"had":[87],"increased":[88,127],"antibody":[89],"responses":[90,107],"as":[91,133],"compared":[92,134],"those":[94],"receiving":[95,144,161],"our":[96],"pWRG7077-based":[98],"IM":[103],"injection,":[104],"these":[106],"were":[108],"further":[109],"enhanced":[110],"inclusion":[113],"genes.":[119],"The":[120],"significantly":[126],"protection":[128],"against":[129],"aerosol":[130],"challenge":[132],"pWRG7077":[137,146],"vaccine.":[140],"Although":[141],"all":[142],"at":[152],"dose":[154],"tested":[155],"survived":[156],"challenge,":[158],"only":[159],"vaccine":[166],"co-expresses":[168],"failed":[174],"lose":[176],"weight":[177],"after":[178],"challenge.":[179],"Our":[180],"results":[181],"suggest":[182],"can":[186],"improve":[187],"immunogenicity":[189],"alphavirus":[194],"filovirus":[196],"vaccines.":[198]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}
